Dr. Rita Dadiz, DO

NPI: 1003016155
Total Payments
$2,064
2023 Payments
$2,064
Companies
1
Transactions
1

Payment Breakdown by Category

Consulting$2,064 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $2,064 1 100.0%

Top Paying Companies

Company Total Records Latest Year
Hikma Pharmaceuticals USA $2,064 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $2,064 1 Hikma Pharmaceuticals USA ($2,064)

All Payment Transactions

1 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
05/12/2023 Hikma Pharmaceuticals USA Phenobarbital (Drug) Consulting Fee Cash or cash equivalent $2,064.00 General
Category: Sleep

About Dr. Rita Dadiz, DO

Dr. Rita Dadiz, DO is a Neonatal-Perinatal Medicine healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003016155.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rita Dadiz, DO has received a total of $2,064 in payments from pharmaceutical and medical device companies, with $2,064 received in 2023. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Consulting Fee" ($2,064).

Practice Information

  • Specialty Neonatal-Perinatal Medicine
  • Location Rochester, NY
  • Active Since 07/18/2007
  • Last Updated 07/06/2023
  • Taxonomy Code 2080N0001X
  • Entity Type Individual
  • NPI Number 1003016155

Products in Payments

  • Phenobarbital (Drug) $2,064

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neonatal-Perinatal Medicine Doctors in Rochester